Medical Media Communications (MMC): Vascular Interventional Advances (VIVA)
10THE PREMIER MULTIDISCIPLINARY VASCULAR EDUCATION EVENT TH Anniversary “ The interaction between clinicians, interventionists, trialists, and policy makers keeps VIVA on the cutting edge. ” “Intellect, interaction,fingertips at the are available at your and innovation speed you want to learn. ” “Looking atunique insight helps to improve with procedures and technology the outcome of patients. ” A Not For Profit Organization Dedicated To Vascular Education And Research
THE VIVA SYMPOSIUM celebrating 10 years of excellence This year, VIVA®, Vascular InterVentional Advances, celebrates its 10th year of defining excellence in vascular medicine and intervention. VIVA 12 offers a jam-packed week of exciting educational sessions for all those involved in the care of patients with vascular disease. For this milestone year, VIVA attendees will experience an incredible symposium, including presentations from a world renowned, multispecialty, international faculty, expanded concurrent and pre-course sessions, state-of-the-art technology with 3D learning tools, and a special evening anniversary event. Since 2003, VIVA has focused intently on keeping the annual conference innovative and fresh, while remaining devoted to the goal of advancing the field of vascular medicine through interdisciplinary education. VIVA has created a true multidisciplinary and collaborative approach to learning, blending faculty and attendees from vascular surgery, interventional cardiology, interventional radiology, vascular medicine, neurointervention/ neurosurgery, and cardiothoracic surgery. This year, VIVA welcomes our podiatric colleagues with a dedicated half-day session and our cardiovascular healthcare professionals with a specialized three-day track. VIVA is proud to assemble a faculty that challenges attendees to critically evaluate evolving trends and to remain at the forefront of the vascular field, all with a spirit of collegiality and camaraderie. For 2012, VIVA plans to push the envelope with topics and discussions in new and improved sessions such as The BLITZ, a case-based, fast- paced educational experience; The Business of Health Care, featuring a renowned professor from Harvard Business School; Strategies on the Frontline, the intense and wildly popular session that debuted in 2011; an expanded International Forum offering even more global perspectives; and a session dedicated to what’s new in limb salvage. With so many opportunities to learn, interact, and engage, attendees are guaranteed an amazing educational experience. As one attendee stated, “if you haven’t been to VIVA lately, you haven’t been to VIVA!” Please Join Us in October for the Premier Vascular Education Event of the Year!2
CONTENTSContinuing Medical Education(CME) Credit Information …………………..... 4-5 IMPORTANT DATES Registration Pricing Schedule The VIVA Experience ………………………..... 6-7 Early Bird .…………….....……………. May 20 - July 31 Prime .…………….......…… August 1 - September 24Special Events …………………………..……... 8-9 Standard .………………..… Beginning September 25 New iPad App ..........……………......….. Available Now!Session Descriptions ………………………. 10-15 Board Review Course …………………...... 10 “Face-Off” Abstract Submission Due Date …… July 15 See page 14 for details. Cardiovascular Healthcare Professionals .... 11 Monday Pre-Symposia ….....…………….... 12 “Face-Off” Notice of Acceptance …...……... August 17 Concurrent Sessions ………..…………. 13-15 On-Site Registration Opens ……..………….. October 6VIVA 12 Faculty ……………..……………… 16-18 CME Certificates Available …………..….… November 5Session Agendas ………..………………….. 19-35 LEARN ENGAGE Monday Pre-Symposia ……….……….. 19-21 INTERACT General Session …………….…………. 22-29 Concurrent Sessions ………..…………. 30-35 CONNECTHotel Information …………………….……….. 36 Learn, engage, interact, and get connected with VIVA all year long.Commercial Supporters & Exhibitors .……....... 37 For weekly emails that you won’t want to miss, signRegistration Information ………………….. 38-39 up for the VIVA Weekly Dose! www.VIVAPVD.com/email/Dose.aspx 3
CME INFORMATION EDUCATIONAL OBJECTIVES VIVA celebrates a decade of providing the leading multispecialty, collaborative education symposium with a focus solely on peripheral vascular diseases. We have remained true to our original goal of teaching those interested in providing the highest level of patient care via an unbiased, comprehensive educational forum covering all aspects of vascular medicine and intervention. At the conclusion of the course, the targeted learners should be able to: Understand the current indications, risks, complications, and long-term results of various medical therapies for the treatment of peripheral atherosclerotic vascular disease. Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with foot ulcers and threatened limbs. Increase awareness and understanding of the complete spectrum of interventional therapies for the treatment of patients with aortic complications. Enhance understanding of venous physiology, anatomy, diseases and management options across a variety of venous territories. Discuss the diagnosis and management of patients with thoracic aortic disease. Increase knowledge of contemporary approaches to carotid artery management based on recent evidence-based data from randomized trials. TARGET AUDIENCE VIVA will be of value to physicians, technologists, physician assistants, nurse practitioners, and nurses who specialize in interventional cardiology, interventional radiology, vascular medicine, vascular surgery, cardiothoracic surgery, neurosurgery, and neuroradiology. VIVA will also offer a new three-day session designed specifically for cardiovascular healthcare professionals (including nurses, vascular clinic staff, endovascular operating room staff, interventional suite staff, nurse practitioners, vascular technologists and physician assistants) who are interested in the management of patients with vascular disease. VIVA also welcomes our podiatric colleagues with a new pre-course session dedicated to critical limb ischemia (CLI) and limb preservation. SEE WHAT’S NEW FOR 2012! www.VIVAPVD.com4
CME ACCREDITATIONThis program has been planned and implemented in accordance with the Essential Areas and Policies of theAccreditation Council for CME (ACCME) through joint sponsorship with the University at Buffalo School of Medicineand Biomedical Sciences and VIVA Physicians. The University at Buffalo is accredited by the ACCME to sponsorCME for physicians. The UB School of Medicine & Biomedical Sciences designates this live activity for a maximumof 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extentof their participation in the activity. Distribution of credits is as follows: Monday: CLI and Limb Preservation: 4.0 Venous Interventions: 4.75 Cardiovascular Healthcare Professionals (CHPS): 7.0 Tuesday: General Session and Chalk Talk/Dialog Session: 7.25 CHPS: 7.75 Wednesday: General Session and Chalk Talk/Dialog Session: 7.25 CHPS: 7.25 International Forum: 4.0 Thursday: General Session and Chalk Talk/Dialog Session: 7.25 International Forum: 8.0 Friday: General Session: 3.75PODIATRISTS: Affiliate sponsorship has been given by the American Podiatric Medical Association (APMA) for4.0 hours of continuing medical education (CME) for Monday’s Critical Limb Ischemia (CLI) & Limb Preservation:A Multidisciplinary Approach symposium. An additional 4.25 contact hours can be earned for attending VIVA 12.Please see www.VIVAPVD.com for more details.NURSES & TECHNOLOGISTS: CNE/CE credits for the Cardiovascular Health Professionals Symposium (CHPS) areavailable. Please see page 11 for details.To Claim Credits: Beginning November 5, 2012, attendees can log on to our website at www.VIVAPVD.comfor information on how to claim educational credits. Detailed instructions can be found in the on-site registrationbooklet received at check-in. DISCLAIMER The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. FACULTY DISCLOSURE University of Buffalo at SUNY, in accordance with ACCME Accreditation requirements, requires faculty to disclose any financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed during this educational activity and with any commercial supporters of the activity. UNLABELED PRODUCTS AND/OR PROCEDURES Faculty at this symposium may discuss information about pharmaceutical agents and/or devices and/or procedures that are outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications, devices and procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. COMMERCIAL FUNDING AND FINANCIAL SUPPORT VIVA 12 is funded by educational grants from various commercial organizations that have no control over program content. See page 37 for a current list of commercial supporters and contributors. A complete list of VIVA 12 supporters and exhibitors will be available on-site and at www.VIVAPVD.com. 5
THE VIVA EXPERIENCE If you haven’t been to VIVA lately, you haven’t been to VIVA! Over the past decade, VIVA has stayed true to its educational mission and has continuously offered the most current and effective medical information to the vascular community. With a goal of providing the most cutting-edge and innovative learning modalities, VIVA has enhanced the learning experience to be interactive, thought-provoking, and state-of-the-art. See what VIVA has to offer: LAPTOP LEARNING ™ Laptop Learning™ is the groundbreaking educational system developed by VIVA in 2003 that integrates a variety of media into an innovative and customizable learning program. It creates an educational platform that engages the participant at his or her current skill/knowledge level and helps target specific learning needs. Laptop Learning™ offers participants secure, private interaction with faculty in real-time, as well as the opportunity to take electronic notes, view extended coverage of live cases, engage in live interactive polling with colleagues, and more. Many meetings have attempted to garner the strength of electronic interaction, but none have matched the power of the Laptop Learning™ system. Laptop Learning™ is more than downloading presentations—it is the new way to learn, at your own pace, with real-time interactivity between the participant and faculty experts. This state-of-the-art, interactive learning tool offers a variety of features, including: Live “Ask the Faculty” computer interface Slide presentations available 24/7 The ability to take electronic notes and save them to your USB drive A robust search engine of published vascular medicine literature Cath-Cam live-case streaming video* Interactive electronic job board Interactive polling Individualized self-assessment tools Course and speaker evaluations Instant access to Coding and Billing sheets for all live cases * Participants interested in more live case time than agenda constraints allow, can view extended live coverage from the laptops. Archived material from the symposium, including case studies and full presentations, will be available online at www.VIVAPVD.com after the program.6
LIVE CASE SITES AND HOSTING PHYSICIANSVIVA will transmit live cases from six leading vascular centers across the United States and Leipzig, Germany.Based on the tenet of optimal patient care, the live case sites present a truly multidisciplinary approach toendovascular therapy. These cases will give attendees the opportunity to observe optimal techniques and learnpractical tips performed live and in real-time. Patients will be enrolled in numerous multi-center, cutting-edgeclinical research trials to complement the on-site didactic lecture series.VIVA 12 is proud to host live case demonstrations from the following sites:ohio health/RIVERSIDE METHODIST HOLY NAME MEDICAL CENTER TEANECK, NEW JERSEYHOSPITAL COLUMBUS, OHIO John Rundback, MD Interventional RadiologyGary Ansel, MD Interventional Cardiology PARK HOSPITAL LEIPZIG LEIPZIG, GERMANYPRESBYTERIAN HEART INSTITUTE DALLAS, TEXAS Andrej Schmidt, MD AngiologyTony Das, MD Interventional Cardiology HAWAII PERMANENTE MEDICAL GROUPEL CAMINO HOSPITAL MOUNTAIN VIEW, CALIFORNIA KAISER FOUNDATION HOSPITAL HONOLULU, HAWAIIJames Joye, DO Interventional Cardiology Peter Schneider, MD Vascular SurgeryMichael Dake, MD Interventional Radiology INTRO IN special opportunity to learn in 3d! VIVA’s determination to provide cutting-edge and innovative learning tools reached a new level in 2011 with the success of the evening premiere of vascular procedures shown in 3D. For VIVA 12,this novel 3D educational tool will be available to every attendee in the General Session! Before each live casedemonstration, attendees will see a brief case in 3D offering interactive instruction and an enhanced perspective.The 3D learning is sure to stimulate your senses and provide an unparalleled educational experience.CHALK TALK & DIALOG SESSIONSThese concurrent sessions provide a myriad of topics with focused instruction by the leading experts. Space islimited to first-come, first-served.Chalk Talks – Rapid paced, purely technical sessions providing 45-minute interactive instruction with VIVAfaculty on specific aspects of vascular medicine and intervention.Dialog Sessions – One-hour sessions providing an exclusive, intimate opportunity for participants to discuss aspecific topic with VIVA faculty in greater depth than what can be covered in a large symposium. The sessionwill consist of a brief presentation by a VIVA faculty member, followed by 40 minutes of questions and answers,discussion of case examples, and a review of current standards of care.LATE-BREAKING DATA… A DOUBLE DOSE!Wednesday and Thursday at 1:20 pm in the General SessionDon’t miss these highly anticipated presentations of late-breaking clinical trial data. You will have two specialopportunities to access results from several major trials as they are discussed by a multispecialty group of panelists.This is the latest trial data that may change your practice! 7
SPECIAL EVENTS GOVERNMENT SUMMIT Wednesday, October 10 at 12:00 pm in Mouton 1 VIVA 12 continues the tradition of collaborating with leaders from the United States Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) in our “Government Summit.” In the past, we have highlighted emerging technologies and evaluated challenges and opportunities from the perspective of our colleagues in the FDA and CMS. This year, for the first time and in keeping with the expanded involvement of our international colleagues, leading representatives from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) will join us. We will compare and contrast regulatory policies and practices and highlight how collaboration has led the way to novel trials, which may result in multinational device approval. Opinions on approaches to drug-coated balloons, renal denervation, and management of critical limb ischemia will be discussed. The VIVA ATLAS Award: “A Teacher, Leader, and Scholar” The VIVA ATLAS award is a distinction bestowed upon an extraordinary individual who has demonstrated leadership, mentorship, and scholarly activity that has profoundly affected the care of patients with vascular disease. VIVA is proud to recognize John A. Spittell Jr., MD as the recipient of this year’s prestigious award. the viva atlas award presentation – John A. Spittell Jr., MD Thursday 8:40 am in the General Session John A. Spittell Jr., MD John Spittell Jr., MD (known as “Jack” by his admirers and friends alike) is the 2012 recipient of the VIVA ATLAS award. Since the ATLAS award is given to those giants in the field of vascular medicine and intervention who have transformed our ability to care for patients through teaching and scholarly activity, there is no one more deserving than Dr. Spittell. After completing his medical school training at the University of Maryland, he was a captain in the U.S. Army Medical Corps, and subsequent to that, completed an internal medicine residency at the Mayo Clinic Foundation. In 1961, he became the head of the section of Peripheral Vascular Diseases at Mayo Clinic, and since then, has held multiple national positions in esteemed organizations, including Chair of the Board of Governors of the American College of Physicians. Dr. Spittell has published extensively in the field of vascular medicine, teaching legions of housestaff the importance of a comprehensive physical examination when determining the appropriate treatment for patients with vascular disease. With his keen eye and wit, Dr. Spittell has shaped the field of vascular medicine and intervention by bringing together all specialties to offer comprehensive care for patients with vascular disease. Many will remember the incredible lectures delivered by Dr. Spittell at the American College of Cardiology symposia, as well as his role as key faculty for the Isner Heart House symposia held in Washington, DC every year. It is an honor to bestow the 2012 ATLAS award to Dr. Jack Spittell, the penultimate teacher, leader, and scholar.8
LIVE Award (Leader in Endovascular Education)This year marks the eighth annual LIVE award presentation at VIVA. Recipients of this awardhave epitomized those vascular specialists who have dedicated their professional careers toeducating students, post-graduate trainees, and peers in all aspects of vascular medicine andintervention.Dr. Dake joins the following LIVE award recipients:2005 – Kenneth Rosenfield, MD 2007 – L. Nelson Hopkins III, MD 2009 – Gary Ansel, MD Interventional Cardiology Neurosurgery Interventional Cardiology2006 – Barry Katzen, MD 2008 – Edward Diethrich, MD 2010 – Michael R. Jaff, DO Interventional Radiology Cardiovascular Surgery Vascular Medicine 2011 – Mark Wholey, MD Michael D. Dake, MD Interventional RadiologyLIVE award presentation – Michael D. Dake, MDWednesday 8:40 am in the General SessionThis year’s LIVE award recipient redefines the award. Michael D. Dake, MD is the Thelma and Henry DoelgerProfessor in the department of Cardiothoracic Surgery at Stanford University. After graduating from HarvardCollege and obtaining his MD degree at Baylor College of Medicine, Dr. Dake completed a residency in InternalMedicine and fellowship in Pulmonary Medicine at Baylor, followed by a residency and fellowship in Radiologyand Interventional Radiology at the University of California, San Francisco. He is currently the director of theCath/Angio suites at Stanford University Medical Center.Dr. Dake has trained over 100 fellows during his career and countless other practicing physicians. He haspublished over 250 original manuscripts, and has received innumerable national and international scholarlyawards, most recently the 2012 Society for Interventional Radiology Foundation Leaders in Innovation Award.Dr. Dake is one of the preeminent leaders in the field, and from his background, it is not at all surprising that hehas worked jointly with multiple specialties throughout his career. It is with this spirit of education, collaboration,and innovation that we proudly recognize Dr. Michael Dake as this year’s LIVE award recipient.THE ANNIVERSARY GALAWednesday, October 10 from 7-10pm @ Encore’s Club XSJoin us for VIVA’s 10th anniversary celebration! After a decade of premier vascular education, we inviteyou to relax and enjoy an evening full of celebration and surprises! Attendance to the Anniversary Gala isincluded in your conference registration fee.Additional tickets will not be sold at the door and must be purchased during your registration process or at the VIVAregistration desk no later than Wednesday at 7:00pm. Registered attendees are welcome to bring a guest for an additional$100 per person. Name badges are required for all attendees and guests, and all participants must be at least 21 years of ageand show a valid ID upon admittance. 9
VIVA & The Society for Vascular Medicine present: VASC UL AR a nd E ND O VA S CU L A R BOARD REVIEW COURSE October 6-8, 2012 WYNN LAS VEGAS VIVA proudly collaborates with the Society for Vascular Medicine (SVM) for the 3rd annual national Vascular and Endovascular Board Review Course (VEBRC). This two-day program is jam-packed with information to assist physicians preparing for the American Board of Vascular Medicine (ABVM) board certification examinations, and is for those who want a detailed, intensive review course including both vascular and endovascular components. In the spirit of providing the highest levels of education and science, the VEBRC offers everything the participant will need in one location CME ACCREDITATION & DESIGNATION with a dedicated faculty and a truly state-of-the-art review course: Physicians: This program has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for CME • TWO FULL DAYS: Saturday, October 6 at 1pm to Monday, (ACCME) through joint sponsorship with the University October 8 at 12pm at Buffalo School of Medicine and Biomedical Sciences • A world-renowned faculty, selected for their ability to and VIVA Physicians. convey the current critical examination components The University at Buffalo is accredited by the ACCME • TWO sample exams and review of answers, addressing to sponsor CME for physicians. The UB School of topics for both the general vascular and endovascular Medicine & Biomedical Sciences designates this live testing areas activity for a maximum of 15.25 AMA PRA Category • VIVA’s Laptop Learning™ module, allowing attendees to 1 Credits™ with the following distribution: take notes, download material, and interact with faculty in Saturday (1:00 pm – 5:00 pm): 3.75 real-time, all via a conference-provided laptop Sunday (8:00 am – 5:00 pm): 7.5 Monday (8:00 am – 12:00 pm): 4.0 • The ability to review all course presentations at any time with synced audio, video, and PowerPoint slides by utilizing VIVA’s Instant Replay system ABVM Examination: Dates for the 2012 ABVM examination(s) are November 27-December 15. Want to extend your knowledge? Please visit www.vascularboard.org for details. Stay for VIVA 12 – the 10th anniversary! The deadline to apply is October 19. FACULTY INCLUDES: Tony Das, MD John Kaufman, MD John Rundback, MD Interventional Cardiology Interventional Radiology Interventional Radiology Gary Ansel, MD Steven Dean, DO Scott Kinlay, MBBS, PhD Robert Schainfeld, DO Interventional Cardiology Vascular Medicine Interventional Cardiology Vascular Medicine Jerry Bartholomew, MD Douglas Drachman, MD Raghu Kolluri, MD Peter Schneider, MD Vascular Medicine Interventional Cardiology Vascular Medicine Vascular Surgery Mark Bates, MD Heather Gornik, MD Christopher Kwolek, MD Timothy Sullivan, MD Interventional Cardiology Vascular Medicine Vascular Surgery Vascular Surgery Joshua Beckman, MD Bruce Gray, DO Robert McBane, MD Michael Wholey, MD Vascular Medicine Vascular Medicine Vascular Medicine Interventional Radiology Mark Burket, MD L. Nelson Hopkins III, MD Suman Rathbun, MD Interventional Cardiology Neurosurgery Vascular Medicine Scan this mobile John Campbell, MD Michael R. Jaff, DO Kenneth Rosenfield, MD barcode for more Vascular Medicine Vascular Medicine Interventional Cardiology information. For a complete agenda and to register, please visit www.VIVAPVD.com10
New Symposium at VIVA 12 – Created Just for Healthcare Professionals!October 8-10, 2012 • Wynn Las VegasNew for 2012 is VIVA’s three-day educational track dedicated to the cardiovascularhealthcare professional. All allied vascular professionals including nurses,vascular clinic staff, endovascular operating room staff, cath lab/angio suitestaff, vascular technologists, nurse practitioners, and physician assistantsshould consider attending this expanded course. A respected faculty willprovide presentations on a wide variety of interesting topics focusing onperipheral arterial disease, venous disease, wound care, non-invasive vasculartesting, and emerging therapies in the cardiac catheterization laboratory.Additionally, CHPS attendees will have the opportunity to view and discuss thelive cases, transmitted in real-time from the General Session.CME ACCREDITATION & DESIGNATIONPhysicians: The University at Buffalo is accredited by the ACCME to sponsor CME for physicians.The UB School of Medicine & Biomedical Sciences designates this live activity for a maximumof 22.0 AMA PRA Category 1 Credits™.Credits for healthcare professionals are also available. Monday: 8:00 am – 5:00 pmFor details, please visit www.VIVAPVD.com/conference Tuesday: 8:00 am – 5:40 pmand select CHPS from the VIVA 12 Highlights menu. Wednesday: 8:00 am – 5:30 pmFACULTY INCLUDES: Karen Fitzgerald, MSN, Debra Kohlman-Trigoboff, Richard Neville, MD RN, NP, CVN ACNP-BC, CVN Vascular SurgeryJoshua Beckman, MDVascular Medicine Kenneth Gorski, RN, RCIS John R. Laird Jr., MD Jeffrey Olin, DO Interventional Cardiology Vascular MedicineCindi Christensen, MSN, William Gray, MDCVN, ARNP Interventional Cardiology Julie Logan, RN Carolyn Robinson, MSN, RN, CANPMark Creager, MD Michael Guiry, MBA, RPA-C Robert Lookstein, MDVascular Medicine Interventional Radiology Kenneth Rosenfield, MD Gail Hadley, RN, RVT Interventional CardiologyTony Das, MD Sean Lyden, MDInterventional Cardiology Michael R. Jaff, DO Vascular Surgery Mitchell Silver, DO Vascular Medicine Interventional CardiologyDavid Dawson, MD Manish Mehta, MDVascular Surgery James Joye, DO Vascular Surgery John Steinberg, DPM Interventional Cardiology Podiatric SurgeryRegina Deible, BSN D. Christopher Metzger, MD John Kaufman, MD Interventional Cardiology Stephanie Yates, MSNDavid Del Pizzo, MHA, RVT Interventional Radiology Scan this mobile barcode for moreFor a complete agenda and to register, please visit us at www.VIVAPVD.com information. 11
PRE-SYMPOSIA SESSIONS VIVA Pre-Symposia – MONDAY, OCTOBER 8, 2012 These sessions are included in VIVA tuition. Venous Interventions: Legs, Lungs, and Neck 1:00 - 6:00 pm in Mouton 1 This course will provide a comprehensive look at some of the hot topics in venous interventions, one of the fastest growing areas of vascular intervention. Do you want to know which of your patients should get pharmacomechanical thrombectomy for deep vein thrombosis, and how best to do this? Are you considering interventions for massive PE? Is there a difference between RF and Laser for varicose veins? And lastly, what about CCSVI - will you be doing this, or should you leave it to someone else? See page 19 for detailed agenda and CME information. •D e b a t e s •Q & A •P a n e l Discussions NEW for PODIATRISTS Critical Limb Ischemia (CLI) & Limb Preservation Special Registration Price! 1:00 - 5:30 pm in Lafite 7 This new half-day session is specifically designed for podiatrists, vascular specialists, cardiovascular healthcare and other medical professionals who care for patients with peripheral arterial disease (PAD). This symposium will focus on patients with the most severe form of PAD, critical limb ischemia (CLI), and opportunities for limb preservation. CLI is an under-recognized problem that is growing due to the increasingly aging population, diabetes, preponderance of metabolic syndrome, and increasing number of chronic kidney disease patients. A dedicated, multispecialty faculty will provide a basic and in-depth review of contemporary diagnostic, clinical, therapeutic, and programmatic considerations for the care of patients with CLI. The program goal is to provide insights and tactical information about the manifestations, diagnosis, and patient care considerations for this population. Didactic and case-based presentations will provide an opportunity for extensive discussion and interaction with the faculty. See page 20 for detailed agenda and CME information. Come to hear your role, your responsibility, your opportunity! The Business of Health care 1:00 - 5:00 pm in Petrus 2 VIVA 12, our 10th anniversary, is an important milestone. As the leading educator in the field of vascular medicine and intervention, VIVA continues to integrate critical components to improve the vascular specialists’ ability to care for patients. As public policy evolves and health care reform becomes a reality, physicians are challenged with a new vernacular….CED….ACO…PCC…AQC…. Where do vascular specialists fit in the new world order? What is the intersection between health care reform evolution and the provider? What must physicians understand? And how can this all be done in an ethical and appropriate environment? VIVA tackles these tough topics and more with internationally recognized experts, industry leaders, physicians involved in the evolution of health care, and invited guests, including a renowned professor from Harvard Business School! See page 21 for detailed agenda. Continuing education credits are not available for this session.12
CONCURRENT SESSIONS VIVA CONCURRENT SESSIONS – TUESDAY - THURSDAY This year, VIVA has FOUR concurrent sessions, each offering something for every attendee! Attendance is included in your tuition. See details below. The BLITZ! Tuesday, October 9, 8:55 am - 4:50 pm in Margaux 1 The Endovascular Join us for this fast-paced, no-huddle learning session featuring small group Equivalent of a speed teaching and case discussions. This session offers rapid presentations “Speed Dating” from VIVA faculty at a variety of stations, each focused on a different vascular Experience! topic. Attendees will have just eight minutes to engage an interesting case before rotating to a new station with a different captivating topic. Abdominal Aorta THE BLITZ will be dynamic, high-energy, and fast-paced. Venous Carotid / Don’t get left behind! Tibial / Stroke Pedal Iliac Thoracic Mesenteric / Aorta SFA Portal Renal Don’t Miss This! Same room, same time... VIVA VOCE [vo cha] Tuesday, October 9, 8:55 am - 4:50 pm in Margaux 1 ¯ ¯ Watch LIVE as top physicians take the “hot seat” for a one-on-one interview with VIVA faculty. In this intimate session of Q&A, interviewers will encourage a no-holds-barred dialog and provocative discussion of vascular headlines. LEARN ENGAGE INTERACT See page 30 for detailed agendas. Continuing education credits are not available for these sessions. See What’s New For 2012! www.VIVAPVD.com 13
CONCURRENT SESSIONS Multi-Day Session! International Forum Wednesday and Thursday, October 10 -11 in Lafleur 1 & 2 See pages 31-33 for detailed agenda and CME information. This forum will provide an open airing of perspectives and a sharing of interventional experiences from leading international sites, including panel and live case discussions with global authorities. This intense two-day experience is designed to expand our knowledge of vascular practices worldwide via an open-minded environment for an interactive exchange of ideas, methodologies, and practices. The world’s leading international vascular care experts will discuss regional variations in the diagnosis and treatment of vascular pathologies, including medical, endovascular, and surgical therapies. Attendees will not only have intimate access to these international key opinion leaders, but will also learn from the top six presenters selected from the Face-Off with VIVA Faculty session, who will showcase their interesting case or educational research to the entire audience. To enhance the inclusive and intimate nature of this course, attendees in the International Forum will have the ability to actively participate, via a live audio and video feed, with the General Session during live cases. WEDNESDAY, OCTOBER 10, 2012 Kick-off with face-off! Face-Off with VIVA Faculty 8:55 am - 12:00 pm in Margaux 1 See page 31 for detailed agenda. Continuing education credits are not available for this session. Before the official start of the International Forum, join us for this lightning round competition series featuring a fast and furious showcase of presentations by vascular experts and trainees from across the globe. International physicians and U.S. fellows will present original research or interesting cases with a focus on complex procedures, complication management, advanced and novel techniques, diagnostic challenges, and/or new technology. Participants will have seven minutes to present (in PowerPoint format) and three minutes of Q&A as they are judged by VIVA faculty who are tasked with selecting six winners who will present in the International Forum on Wednesday afternoon and Thursday. Three fellows will win the new iPad and the top three international winners will be awarded a two week ‘hands-on’ vascular and endovascular training at the Albany Vascular International Academy, The Institute for Vascular Health & Disease @ Albany Medical Center in New York. For abstract submission instructions, visit www.VIVAPVD.com/conference and select “Face-Off with VIVA Faculty” from the VIVA 12 Highlights menu. CELEBRATING TEN YEARS OF VASCULAR EDUCATION!14
Multi-Day Session! THE ORIGINAL STRATEGIES ON THE FRONTLINEWednesday and Thursday, October 10 -11 in Margaux 2 See pages 34-35 for detailed agenda.Continuing education credits are not available for this session. It’s never the wrong time to practice the basics while learning tips and pearls from the pros–and this year,following a wildly popular response to its debut in 2011, VIVA offers a newly buffed training experience aspart of an intense two-day program designed to upgrade your procedural skills through tactical andstrategic sessions held in a no-nonsense situation room setting.On Wednesday, enter The Presentation Bunker, where it’s a non-stop serving of cases, and nothing butcases ALL DAY! Whether you choose to enlist in the whole tour or join for instruction focused on aparticular vascular territory, your hard-nosed drill leaders are determined to expand the boundaries ofyour current understanding.The Strategies sessions wrap up on Thursday when the council chamber becomesThe Hurt Locker, where the realities of complications are exposed and dissected byexpert vascular operatives who know only too well, the situation: Armageddon wasyesterday – today we have a serious problem. e Th ion uat m Sit oo r for updated PROGRAM information visit www.VIVAPVD.com 15
FACULTY VIVA Steering Committee GARY M. ANSEL, MD JAMES D. JOYE, DO KRISHNA ROCHA-SINGH, MD Interventional Cardiology Interventional Cardiology Interventional Cardiology Riverside Methodist Hospital El Camino Hospital Prairie Vascular Institute Columbus, Ohio Mountain View, California Springfield, Illinois Joshua A. Beckman, MD JOHN A. KAUFMAN, MD KENNETH ROSENFIELD, MD Vascular Medicine Interventional Radiology Interventional Cardiology Brigham and Women’s Hospital Dotter Interventional Institute Massachusetts General Hospital Boston, Massachusetts Portland, Oregon Boston, Massachusetts MICHAEL D. DAKE, MD JOHN R. LAIRD JR., MD John H. Rundback, MD Interventional Radiology Interventional Cardiology Interventional Radiology Stanford University Medical Center UC Davis Medical Center Holy Name Hospital Stanford, California Sacramento, California Teaneck, New Jersey TONY S. DAS, MD Sean P. Lyden, MD PETER A. SCHNEIDER, MD Interventional Cardiology Vascular Surgery Vascular Surgery Presbyterian Heart Institute Cleveland Clinic Hawaii Permanente Medical Group Dallas, Texas Cleveland, Ohio Honolulu, Hawaii MICHAEL R. JAFF, DO MANISH MEHTA, MD Vascular Medicine Vascular Surgery Massachusetts General Hospital The Institute for Vascular Health and Disease Boston, Massachusetts Albany, New York Faculty John Fritz Angle, MD Daniel G. Clair, MD Colin Derdeyn, MD Interventional Radiology Vascular Surgery Neuroradiology University of Virginia Health System Cleveland Clinic Barnes Jewish Hospital Charlottesville, Virginia Cleveland, Ohio St. Louis, Missouri Vinay Badhwar, MD Mark A. Creager, MD Matthew Eagleton, MD Cardiothoracic Surgery Vascular Medicine Vascular Surgery University of Pittsburgh Medical Center Brigham and Women’s Hospital Cleveland Clinic Pittsburgh, Pennsylvania Boston, Massachusetts Cleveland, Ohio Subhash Banerjee, MD R. Clement Darling, MD Mark Eskandari, MD Interventional Cardiology Vascular Surgery Vascular Surgery VA North Texas Health Care System Albany Medical Center Hospital Northwestern Memorial Hospital Dallas, Texas Albany, New York Chicago, Illinois James Benenati, MD Srikant Datar, phd Mark Farber, MD Interventional Radiology Harvard Business School Vascular Surgery Baptist Cardiac & Vascular Institute Boston, Massachusetts UNC Hospitals Miami, Florida Chapel Hill, North Carolina David Dawson, MD Robert Bersin, MD Vascular Surgery Michael Fischbein, MD Interventional Cardiology UC Davis Vascular Center Cardiothoracic Surgery Seattle Cardiology Sacramento, California Stanford Hospital and Clinics Seattle, Washington Stanford, California David Hugo Deaton, MD Mark Burket, MD Vascular Surgery Lawrence Garcia, MD Interventional Cardiology Georgetown University Hospital Interventional Cardiology University of Toledo Medical Center Washington, DC St. Elizabeth’s Medical Center Toledo, Ohio Boston, Massachusetts16
Heather L. Gornik, MD Alan B. Lumsden, MD Geoffrey Rubin, MDVascular Medicine Vascular Surgery Cardiovascular RadiologyCleveland Clinic Methodist DeBakey Heart & Vascular Center Duke University Medical CenterCleveland, Ohio Houston, Texas Durham, North CarolinaBruce Gray, DO Raj Makkar, MD Richard Saxon, mdVascular Medicine Interventional Cardiology Interventional RadiologyGreenville Memorial Hospital Cedars-Sinai Medical Center North County RadiologyGreenville, South Carolina Los Angeles, California Encinitas, CaliforniaWilliam Gray, MD Alan H. Matsumoto, MD Interventional Radiology Dierk Scheinert, MDInterventional Cardiology Angiology University of Virginia Health SystemNew York Presbyterian Medical Center Park Hospital Leipzig Charlottesville, VirginiaNew York, New York Leipzig, Germany Jon Matsumura, MDLanfroi Graziani, MD Vascular Surgery Gary Siskin, MDInterventional Cardiology University of Wisconsin Hospitals and Clinics Interventional RadiologyIstituto Clinico Città di Brescia Hospital Albany Medical Center Hospital Madison, WisconsinBrescia, Italy Albany, New York D. Christopher Metzger, MDZiv J. Haskal, MD Interventional Cardiology Benjamin W. Starnes, MDInterventional Radiology Wellmont CVA Heart Institute Vascular SurgeryUniversity of Maryland School of Medicine Kingsport, Tennessee Harborview Medical CenterBaltimore, Maryland Seattle, Washington Jihad A. Mustapha, MDL. Nelson Hopkins III, MD Interventional Cardiology Timothy Sullivan, MDNeurosurgery Metro Health Hospital Vascular SurgeryMillard Fillmore Gates Hospital Wyoming, Michigan Abbott Northwestern HospitalBuffalo, New York Richard Neville, MD Minneapolis, MinnesotaWilliam D. Jordan Jr., MD Vascular SurgeryVascular Surgery George Washington University Hospital Thoralf Sundt iii, mdThe Kirklin Clinic Washington, DC Cardiothoracic Vascular SurgeryBirmingham, Alabama Massachusetts General Hospital Gustavo Oderich, MD Boston, MassachusettsStephen Kee, MD Vascular SurgeryInterventional Radiology Mayo Clinic Thomas T. Tsai, MDUCLA Medical School Rochester, Minnesota Interventional CardiologyLos Angeles, California Denver VA Medical Center Jeffrey W. Olin, DO Denver, Colorado Vascular MedicineZvonimir Krajcer, MD Mount Sinai Medical Center Suresh Vedantham, MDInterventional Cardiology New York, New York Interventional RadiologyTexas Heart Institute atSt. Luke’s Episcopal Hospital Constantino Peña, MD Mallinckrodt Institute of RadiologyHouston, Texas Interventional Radiology St. Louis, Missouri Baptist Cardiac & Vascular InstituteChristopher Kwolek, MD Miami, Florida frank J. Veith, MDVascular Surgery Vascular SurgeryMassachusetts General Hospital Alice Perlowski, MD Cleveland Clinic/New York UniversityBoston, Massachusetts Interventional Cardiology Cleveland, Ohio/New York, New York Chicago, IllinoisJason T. Lee, MD Eric Verhoeven, MD, PhDVascular Surgery Mahmood Razavi, MD Vascular SurgeryStanford University Medical Center Interventional Radiology Klinikum NürnbergStanford, California St. Joseph Heart and Vascular Center Nürnberg, Germany Orange, CaliforniaMartin Leon, MD Edward Y. Woo, MD Scott Resnick, mdInterventional Cardiology Vascular Surgery Interventional RadiologyColumbia University Medical Center University of Pennsylvania Northwestern Memorial HospitalNew York, New York Philadelphia, Pennsylvania Chicago, IllinoisRobert Lookstein, MD Anne Roberts, MD Thomas Zeller, MDInterventional Radiology Interventional Radiology AngiologyMount Sinai Medical Center Thornton Hospital/UCSD Medical Center Herz-Zentrum, Bad KrozingenNew York, New York La Jolla, California Bad Krozingen, Germany 17
FACULTY International Forum Faculty Roberto Beck, MD Daisuke Fukui, MD, PhD Pankaj Patel, MBBS Interventional Radiology Cardiovascular Surgery Vascular Surgery Dona Helena Hospital Shinshu University School of Medicine Lilavati Hospital and Research Center Santa Catarina, Brazil Nagano, Japan Mumbai, India Varinder Bedi, MD Roger M. Greenhalgh, MD Vincent Riambau, MD, PhD Vascular Surgery Vascular Surgery Vascular Surgery Army Hospital R & R, Delhi Cantt Charing Cross Hospital Hospital Clinic New Delhi, India London, United Kingdom Barcelona, Spain Jacques Busquet, MD Wei Guo, MD Roberto Sacilotto, PhD Vascular Surgery Vascular Surgery Vascular Surgery Clinique Chirurgicale Val d’Or - Foch Chinese PLA General Hospital Hospital do Servidor Publico Foundation Group Beijing, China Estadual de São Paulo Paris, France São Paulo, Brazil Andrew Holden, MD Nick John Cheshire, MD Interventional Radiology Ferdinand Serracino-Inglott, md Vascular Surgery Auckland Hospital Vascular Surgery St. Marys Hospital Auckland, New Zealand Manchester Royal Infirmary London, United Kingdom Manchester, United Kingdom Armando Lobato, MD Augustin James DeLago, MD Vascular Surgery Pierre Galvagni Silveira, MD, PhD Interventional Cardiology São Paulo Vascular & Endovascular Vascular Surgery Albany Medical Center Hospital Surgery Institute Universidade Federal de Santa Catarina New York, USA São Paulo, Brazil Santa Catarina, Brazil Koen Deloose, MD Sumaira Macdonald, MD Peter Richard Taylor, MD Vascular Surgery Interventional Radiology Vascular Surgery Sint Blasius Hospital Freeman Hospital Guy’s & St Thomas’ NHS Foundation Trust Flanders, Belgium Newcastle upon Tyne, United Kingdom London, United Kingdom Walter Dorigo, MD Marco Manzi, MD Hence J. Verhagen, MD Vascular Surgery Interventional Radiology Vascular Surgery Careggi Hospital Policlinico Abano Terme Erasmus University Medical Center Florence, Italy Abano Terme, Italy Rotterdam, The Netherlands Marcelo Ferreira, MD Frans Moll, MD, PhD Vascular Surgery Vascular Surgery SITE Medical Services University Medical Center Utrecht Rio de Janeiro, Brazil Utrecht, The Netherlands18
PRE-SYMPOSIAMONDAY, OCTOBER 8, 2012 • AGENDAThe following Monday pre-symposia sessions are included in your tuition.VENOUS INTERVENTIONS: LEGS, LUNGS, AND NECK 1:00 – 6:00 pm in Mouton 1 NEW!This course will address the hot topics in venous interventions. Please see page 12 for full course description.This session is accredited for 4.75 CME credits. 1:00 - 1:20 pm The New Anticoagulants That You Need to Know About Joshua Beckman, MD 1:20 - 1:40 pm Imaging Acute and Chronic VTE Constantino Peña, MD 1:40 - 2:00 pm Tools of the Trade: What Works for Acute DVT Mahmood Razavi, MD 2:00 - 2:20 pm Tools of the Trade: What Works for Chronic DVT Christopher Kwolek, MD 2:20 - 2:40 pm DVT Intervention Trials and Guidelines Update Suresh Vedantham, MD IVC Filter Point-Counterpoint 2:40 - 2:50 pm IVC Filters are Mandatory During Interventions for Acute Iliofemoral DVT Alan Lumsden, MD 2:50 - 3:00 pm IVC Filters are NOT Mandatory During Interventions for Acute Iliofemoral DVT Scott Resnick, MD 3:00 - 3:05 pm Grill the Speakers: Q&A Moderator: John Kaufman, MD Panel: Joshua Beckman, MD; Christopher Kwolek, MD; Alan Lumsden, MD; Constantino Peña, MD; Mahmood Razavi, MD; Scott Resnick, MD; Suresh Vedantham, MD 3:05 - 3:20 pm REFRESHMENT BREAK Throughout the Course: 3:20 - 3:40 pm How to Get IVC Filters Out John Kaufman, MD •D e b a t e s •Q & A S e s s i o n s •P a n e l Discussions 3:40 - 4:00 pm Massive PE Interventions Kenneth Rosenfield, MD 4:00 - 4:20 pm Submassive PE: When to Intervene and How Scott Resnick, MD 4:20 - 4:40 pm Panel Discussion/Q&A Moderator: John Kaufman, MD Panel: Scott Resnick, MD; Kenneth Rosenfield, MD 4:40 - 5:00 pm Chronic Venous Insufficiency: Who to Treat Robert Lookstein, MD 5:00 - 5:20 pm Endovenous Ablation Technologies: Is There Really a Difference? John Kaufman, MD 5:20 - 5:40 pm What We Need to Learn About CCSVI Manish Mehta, MD 5:40 - 6:00 pm CCSVI Intervention: What it Really Takes to Offer This Gary Siskin, MD 6:00 pm Open Forum: Q&A Moderator: John Kaufman, MD Panel: Robert Lookstein, MD; Manish Mehta, MD; Scott Resnick, MD; Gary Siskin, MD See What’s New For 2012! www.VIVAPVD.com 19
MONDAY, OCTOBER 8, 2012 • PRE-SYMPOSIA NEW for PODIATRISTS CRITICAL LIMB ISCHEMIA (CLI) & LIMB PRESERVATION: Special Registration Price! A MULTIDISCIPLINARY APPROACH 1:00 – 5:30 pm in Lafite 7 A new session specifically designed for those who care for patients with PAD, including the most severe form of this disease, CLI. Please see page 12 for full course description. This session is accredited for 4.0 CME credits and 4.0 CME contact hours through the APMA. 1:00 - 1:05 pm Course Introduction Richard Neville, MD; John Rundback, MD DIAGNOSTIC ASSESSMENT OF CLI 1:05 - 1:15 pm How Extensive is the Problem and What are the Implications for Our Health Care System Tony Das, MD 1:15 - 1:25 pm The “Up-to-Date” Vascular Lab - Basic Testing to Assure Success in the Limb Salvage World Heather Gornik, MD 1:25 - 1:35 pm Assessing Perfusion in the Foot: Techniques and Implications for Revascularization Mark Creager, MD 1:35 - 1:45 pm Cross-Sectional Imaging of the Threatened Limb: What to Order, When to Order it, and Why it is Important Robert Lookstein, MD NAVIGATING THE “BELOW KNEE” ARTERIAL TREE 1:45 - 1:55 pm Normal and Variant Calf and Pedal Arterial Anatomy - Understanding Angiosomes and Their Relevance for Treatment Marco Manzi, MD 1:55 - 2:05 pm Endovascular Revascularization for Limb Preservation: Basic Techniques John Laird, MD 2:05 - 2:15 pm Endovascular Revascularization for Limb Preservation: Advanced Techniques John Rundback, MD 2:15 - 2:25 pm A Brave, New World: Plantar-Pedal Loop Techniques Lanfroi Graziani, MD 2:25 - 2:35 pm What is the Role of the Interventionalist (IC/IR/VS) in a Limb Preservation Program? Sean Lyden, MD 2:35 - 3:05 pm Case Reviews John Rundback, MD 3:05 - 3:30 pm REFRESHMENT BREAK WOUND CARE AND THE SURGEON 3:30 - 3:40 pm Surgical Bypass for Limb Preservation; Sometimes It’s Still the Right Thing Richard Neville, MD 3:40 - 3:50 pm Prosthetic Conduit for Limb Preservation; the International Experience Walter Dorigo, MD 3:50 - 4:00 pm The Microbiology of Wound Care; How Do We Fight Infection and Does Biofilm Really Matter? Christopher Attinger, MD 4:00 - 4:10 pm Achieving Closure and Healing - Management of Wound Healing from Debridement to Biotech John Steinberg, DPM 4:10 - 4:20 pm Advanced Plastic and Surgical Techniques for Healing Challenging Wounds Frank Tursi, DPM 4:20 - 4:50 pm Case Reviews Richard Neville, MD20 Agenda subject to change.
Continued CREATING A HEALING ENVIRONMENT - PROGRAM DEVELOPMENT4:50 - 5:00 pm How to Build a Limb Preservation Program; Assembling the Pieces Richard Neville, MD5:00 - 5:30 pm Panel Discussion: Limb Preservation Programs Moderator: John Rundback, MD Panel: Mark Creager, MD; Lanfroi Graziani, MD; Richard Neville, MD; John Steinberg, DPM; Frank Tursi, DPM 5:30 pm Adjourn Come to hear your role, your responsibility, your opportunity!THE BUSINESS OF HEALTH CARE 1:00 – 5:00 pm in Petrus 2A course addressing the role of vascular specialists in public policy and health care reform. Included in this sessionis an in-depth discussion of a fictional case, available for participants to download and review at www.VIVAPVD.com.Please see page 12 for full course description. Continuing education credits are not available for this session.1:00 - 1:10 pm Welcome and Introductions Michael R. Jaff, DO1:10 - 1:30 pm The Challenges and Opportunities of Health Care Reform on Hospitals - Big, Medium, and Small Ann Prestipino, MPH1:30 - 1:50 pm The Challenges of Health Care Reform on the Medical Device Industry; Current and Future Stacy Enxing Seng, MBA1:50 - 2:50 pm A Case Study for Vascular Specialists Instructor: Michael R. Jaff, DO Panel: Michael Dake, MD; Stacy Enxing Seng, MBA; Robert Hopkins; Louis Jacques, MD; Ann Prestipino, MPH; Kenneth Rosenfield, MD; Gwen Watanabe, MSME, MBA2:50 - 3:15 pm REFRESHMENT BREAK3:15 - 3:40 pm CMS and Health Care Reform - Insights from the Front Lines Louis Jacques, MD3:40 - 4:00 pm Financial Markets and Health Care Reform - Clashes and Opportunities Robert Hopkins4:00 - 4:30 pm Perspectives on the U.S. Health Care Scene from a Harvard Business School Professor Srikant Datar, PhD4:30 - 5:00 pm Panel Discussion/Q&A Moderator: Michael R. Jaff, DO Panel: Michael Dake, MD; Stacy Enxing Seng, MBA; Robert Hopkins; Louis Jacques, MD; Tamara Syrek Jensen, JD; Ann Prestipino, MPH 5:00 pm Symposium Concludes Invited Guests: Stacy Enxing Seng, MBA Louis Jacques, MD Ann Prestipino, MPH Covidien Centers for Medicare & Massachusetts General Hospital Medicaid ServicesSrikant Datar, PhD Robert Hopkins Gwen Watanabe, MSME, MBAHarvard Business School Banc of America Securities Tamara Syrek Jensen, JD Hotspur Technologies, Inc. Merril Lynch Centers for Medicare & Medicaid Services 21
VIVA 12 AGENDA TUESDAY, OCTOBER 9, 2012 • DAY 1 Join us for a VIVA 12 8:00 - 8:05 am Welcome to VIVA 12! Tony Das, MD concurrent session! BIG PICTURE ISSUE: The FuTure of SFA Technology and v endovascular Treatment - What does it look like in 5 years? 8:55 am - 4:50 pm 8:05 - 8:12 am When Will We Use Bare Stents and Will New Stent Designs Provide Better THE BLITZ! Results and Value? D. Christopher Metzger, MD Small group speed teaching, fast-paced case discussions, and 8:10 - 8:55 am CHALK TALK rapid presentations from VIVA faculty at various vascular stations. 8:12 - 8:19 am Will Endoluminal Bypass with Stent-Grafts Become the Default Therapy Located in Margaux 1 for Long Lesions and Extensive Disease – What’s Necessary to Make This See page 30 for agenda. Happen? Richard Saxon, MD 8:19 - 8:26 am How Often Will We Use Drug-Eluting Stents – What Patients/Lesions Will v be the Most Likely to Benefit? Michael Dake, MD 8:55 am - 4:50 pm 8:26 - 8:33 am Will Drug-Coated Balloons be the Next Workhorse Technology and What are the Anticipated Practical Limitations? Tony Das, MD VIVA VOCE [vo cha] ¯ ¯ Top physicians take the “hot seat” to dicuss vascular headlines with 8:33 - 9:32 am LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist Hospital VIVA faculty. Moderator: Tony Das, MD INTRO IN Panel: Bruce Gray, DO; Martin Leon, MD; Marco Manzi, MD; Located in Margaux 1 See page 30 for agenda. Richard Neville, MD; Constantino Peña, MD; Gary Siskin, MD 9:32 - 9:39 am Is There a Role for Spot-Tacking of PTA/DCB Dissection Failures to Avoid Stent Placement – is This a Viable Hybrid Solution? David Deaton, MD 9:39 - 9:46 am Will the Advantages of Percutaneous Extraluminal Bypass Make it in Everyday Procedure in 5 Years Alan Lumsden, MD 9:46 - 9:53 am Are Bioresorbable Vascular Scaffolds Really Necessary – Will They Get Approved, at What Cost, and When? Robert Bersin, MD 9:53 - 10:10 am 10th ANNIVERSARY KEYNOTE ADDRESS: Moral and Ethical Expectations of Leaders Srikant Datar, PhD 8:10 - 8:55 am 10:10 - 10:40 am REFRESHMENT BREAK Chalk Talk 10:40 -11:01 am When My “Go-To” Therapy is Not the Right Choice: How I Blend Imaging, When Not to Do Carotid Endarterectomy Daniel Clair, MD Laboratory Exams, and Clinical When Carotid Artery Stent Placement is a Mistake William Gray, MD Evaluation to Diagnose and When Best Medical Therapy is Not Appropriate Heather Gornik, MD Manage Vasculitides Moderator: Michael R. Jaff, DO 11:01 am - 12:00 pm LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist Panel: Mark Creager, MD; Hospital and El Camino Hospital Heather Gornik, MD; INTRO IN Moderator: Joshua Beckman, MD Sumaira Macdonald, MD; Panel: Vinay Badhwar, MD; James Benenati, MD; Mark Burket, MD; Jeffrey Olin, DO Christopher Kwolek, MD; Jeffrey Olin, DO; Suresh Vedantham, MD Located in Alsace 1 12:00 - 1:20 pm LUNCH / SATELLITE SYMPOSIA THORACIC AORTA 1:20 - 1:28 pm CURRENT PRACTICE - ASSESSING YOUR PATIENT: How I Analyze Acute Aortic Dissection and Symptomatic Aortic Intramural Hematoma: What’s Needed to Develop a Management Plan John Kaufman, MD22 Agenda subject to change.
1:28 - 1:36 pm Uncomplicated Type B Aortic Dissection – Do We Currently Know Who concurrent sessionS Benefits from a More Aggressive Approach and Should We be Parsing ...Continued Patients into More Detailed Subgroups? Edward Woo, MD v 1:36 - 1:57 pm Why I Do What I Do: A Decision Support Analysis for Chronic Type B THE BLITZ! Dissection with Aneurysm Formation: Located in Margaux 1 Open Surgery is the Best Treatment Because It’s Definitive Thoralf Sundt, MD See page 30 for agenda. TEVAR with or without Adjunctive Endovascular Maneuvers is Less Risky and Just as Protective as Operative Repair Benjamin Starnes, MD v The Spectrum of Adjunctive Endovascular Techniques to Promote False VIVA VOCE [vo cha] ¯ ¯ Lumen Thrombosis After TEVAR for Aortic Dissection – Why This is an Important Goal Manish Mehta, MD Located in Margaux 1 See page 30 for agenda. 1:57 - 3:06 pm LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist Hospital and El Camino Hospital INTRO IN Moderator: Manish Mehta, MD Panel: Lawrence Garcia, MD; Robert Lookstein, MD; Alan Lumsden, MD; Alice Perlowski, MD; Dierk Scheinert, MD 3:06 - 3:20 pm DEBATE: Snorkels, Chimneys, Periscopes, and Sandwiches are Now Main Stream, Well-Established Techniques to Expand TEVAR/EVAR Applications Nonsense, These are Only Temporary Place Holders; Gimmicks that Should be Reserved Only for Bail-Outs Because They are Doomed to Fail if Used in Inadequate Aortic Necks Christopher Kwolek, MD Without a Doubt, These are Positive Adjuncts that Allow Us to Successfully Deliver Endovascular Treatment to more Extensive Aortic Disease – These Valuable Techniques are Here to Stay Jason Lee, MD 3:20 - 3:50 pm REFRESHMENT BREAK CARDIAC/STRUCTURAL HEART 3:50 - 4:50 pm 3:50 - 4:50 pm DIALOG SESSION DIALOG SESSION The Spectrum of Metabolic 3:50 - 3:57 pm Minimally Invasive Open Approaches to Cardiac Valve Repair and and Connective Tissue Replacement: How and Why I Do It Vinay Badhwar, MD Diseases that Affect the Aorta; What You Need 3:57 - 4:04 pm CURRENT PRACTICE - ASSESSING YOUR PATIENT: Selecting the Right to Know Patients for TAVI Martin Leon, MD Moderator: Sean Lyden, MD 4:04 - 4:25 pm DEBATE: My Preferred Approach to TAVR is Best for Patients Because... Panel: Michael R. Jaff, DO; Trans-Apical Delivery is Easier and Has Better Outcomes With Less Stroke Christopher Kwolek, MD; Michael Fischbein, MD Alan Lumsden, MD; Constantino Peña, MD Trans-Femoral Introduction is Less Invasive, Simpler, and Has Less Morbidity Located in Alsace 1 Raj Makkar, MD Nontraditional Access Routes to the Aortic Valve are Frequently the Best Choice Timothy Sullivan, MD 4:25 - 5:40 pm LIVE CASE DEMONSTRATIONS: El Camino Hospital Moderator: John Laird, MD INTRO IN Panel: Fritz Angle, MD; David Deaton, MD; Lanfroi Graziani, MD; Louis Jacques, MD; Mahmood Razavi, MD; Benjamin Starnes, MD 5:40 pm DAY ONE CONCLUDES / SATELLITE SYMPOSIA 23
WEDNESDAY, OCTOBER 10, 2012 • DAY 2 Join us for a VIVA 12 7:00 - 8:00 am Satellite Symposia concurrent session! 8:05 - 8:10 am Review of Tuesday’s Live Cases Gary Ansel, MD v RENAL/HYPERTENSION/MESENTERIC 8:55 am - 5:30 pm INternational FORUM 8:10 - 8:18 am What’s the Future of Renal Artery Stenting – Is It a Historical Relic or International perspectives presented Will New Studies Dust It Off and Get It Off the Shelf? Michael R. Jaff, DO by world-renowned faculty. Face-Off with VIVA Faculty 8:18 - 8:26 am How do We Get Our Head Around Renal Denervation for Hypertension – A half-day competition series How Big is It, Who Gets Treated, What Can We Expect? Mark Burket, MD featuring international physicians and domestic fellows. Winners 8:26 - 8:34 am Alternatives to RF Renal Nerve Ablation – Do Fast Followers Have will advance to present in the Something Better to Offer? Krishna Rocha-Singh, MD International Forum. Located in Margaux 1 8:34 - 8:42 am SPECIAL FEATURE – This Is How I Do It: My Strategy for Managing See pages 31-32 for agenda. Renal and Visceral Aneurysms: Assessment, Planning, Techniques, Procedural Decisions Fritz Angle, MD v 8:42 - 8:45 am LIVE Award Presentation (Leader In EndoVascular Education) Honoring Michael Dake, MD for his contribution to endovascular education and patient care. Presented by Michael R. Jaff, DO 8:45 - 10:00 am LIVE CASE DEMONSTRATIONs: Holy Name Hospital Moderator: Michael R. Jaff, DO 8:10 am - 5:30 pm INTRO IN Panel: Clement Darling, MD; Louis Jacques, MD; Jason Lee, MD; The Presentation Bunker D. Christopher Metzger, MD; Scott Resnick, MD; Timothy Sullivan, MD A non-stop serving of cases, and nothing but cases ALL DAY! 8:55 - 9:40 am CHALK TALK Located in Margaux 2 See page 34 for agenda. VASCULAR DIAGNOSIS 10:00 - 10:08 am CURRENT PRACTICE – ASSESSING YOUR PATIENT: Vascular Disease in Young Adults – What Should I be Thinking and More Importantly, Doing to Diagnose and Treat? Mark Creager, MD 10:08 - 10:16 am The Current Status of Bone Marrow-Derived Stem Cell Therapies for CLI: When is It Appropriate, How is It Done, and What Should We Expect? Jeffrey Olin, DO 8:55 - 9:40 am Chalk Talk 10:16 - 10:25 am Molecular Imaging of Vascular Disease Now and in the Future: What Pedal Loop Interventions: Should We Expect and What Will It Contribute? Geoffrey Rubin, MD When, How, and What are the Results? 10:25 - 10:55 am REFRESHMENT BREAK Moderator: Tony Das, MD 10:55 am - 12:00 pm LIVE CASE DEMONSTRATIONS: Holy Name Hospital and Panel: Lanfroi Graziani, MD; Kaiser Foundation Hospital Marco Manzi, MD; INTRO IN Moderator: Michael Dake, MD Dierk Scheinert, MD; Panel: Robert Bersin, MD; Mark Burket, MD; Daniel Clair, MD; Thomas Zeller, MD Robert Lookstein, MD; Gustavo Oderich, MD; Geoffrey Rubin, MD Located in Alsace 1 12:00 - 1:20 pm LUNCH / SATELLITE SYMPOSIA 1:20 - 2:00 pm LATE-BREAKING CLINICAL TRIALS Moderator: Gary Ansel, MD24 Agenda subject to change.
2:00 - 3:00 pm 2:00 - 3:00 pm DIALOG SESSION DIALOG SESSION 2:00 - 3:06 pm LIVE CASE DEMONSTRATIONS: Holy Name Hospital and How to Better Manage Kaiser Foundation Hospital Diabetic Vascular Disease: Is INTRO IN Moderator: John Kaufman, MD Diabetic Atheroma Different Panel: Michael Fischbein, MD; Lawrence Garcia, MD; William Gray, MD; from Non-Diabetic Arterial Nick Hopkins, MD; Dierk Scheinert, MD; Benjamin Starnes, MD Disease and Does it Matter? Moderator: Joshua Beckman, MD ILIAC & SFA Panel: Subhash Banerjee, MD; Mark Burket, MD; 3:06 - 3:14 pm Why I Do What I Do: How the Recent Trials and My Experience Inform My Michael R. Jaff, DO; Approach to Iliac Occlusive Disease: Stent-Grafts Versus Bare Stents Richard Neville, MD Alan Matsumoto, MD Located in Alsace 1 3:14 - 3:22 pm SPECIAL FEATURE – This Is How I Do It: My “Go-To” Techniques for Recanalization and Re-Entry During Treatment of Total Occlusions James Joye, DO 3:22 - 3:30 pm Why I Do What I Do: When to Use Distal Embolic Protection and Lower Extremity Interventions Subhash Banerjee, MD 3:30 - 3:55 pm REFRESHMENT BREAK concurrent sessionS 3:55 - 4:03 pm CURRENT PRACTICE – ASSESSING YOUR PATIENT: How I Use Imaging ...Continued to Stratify Patients with Femoropopliteal Disease into Specific Treatment v Algorithms Robert Lookstein, MD INternational FORUM 4:03 - 4:17 pm DEBATE: What Should We Currently Think of Atherectomy and Debulking? International perspectives presented by world-renowned faculty. Once Upon a Time, Debulking was a Promising Idea, but that Time is Gone Located in Margaux 1 Mahmood Razavi, MD See pages 31-32 for agenda. “Not so fast,” Recent Studies Show that Atherectomy is Better than Most Endovascular Procedures and It Leaves Nothing Behind Lawrence Garcia, MD 4:17 - 4:25 pm Is There a Proven Value to Anti-Platelet Therapy After Endovascular PAD Procedures; if so, Does Everyone Need It or Only Certain Patients? Bruce Gray, DO 4:25 - 5:30 pm LIVE CASE DEMONSTRATIONS: Kaiser Foundation Hospital Moderator: Gary Ansel, MD The Presentation Bunker INTRO IN Panel: David Dawson, MD; Jason Lee, MD; Jihad Mustapha, MD; Located in Margaux 2 Alice Perlowski, MD; Richard Saxon, MD; Edward Woo, MD See page 34 for agenda. 5:30 pm DAY TWO CONCLUDESSPECIAL EVENT7:00 - 10:00 pm THE ANNIVERSARY GALA Wednesday, October 10 @ Encore’s Club XS Join us for VIVA’s 10th anniversary celebration! Attendance to the Anniversary Gala is included in your conference registration fee. 25
THURSDAY, OCTOBER 11, 2012 • DAY 3 Join us for a VIVA 12 7:00 - 8:00 am Satellite Symposia concurrent session! 8:05 - 8:10 am Review of Wednesday’s Live Cases John Rundback, MD v LINC FEATURED SYMPOSIUM: 7:55 am - 5:30 pm CRITICAL LIMB ISCHEMIA INternational FORUM 8:10 - 8:18 am CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Diagnostic International perspectives presented by world-renowned faculty. Evaluation of CLI and How It Influences My Treatment Strategy James Benenati, MD Located in Margaux 1 See pages 32-33 for agenda. 8:18 - 8:26 am What Does the Angiosome Concept Practically Add to My Procedure Planning and Technique for Treating CLI Patients – is a Custom-Tailored v Approach, the Future? John Rundback, MD 8:26 - 8:34 am Is There a Hierarchical Clinical Benefit to Using Drug-Eluting Technologies Over POBA and Bare Stents for Tibial Disease; if so, in What Conditions and for What Lesions is It Obvious? Dierk Scheinert, MD 8:10 am - 5:30 pm 8:34 - 8:42 am Why I Do What I Do: My Approach to the Evaluation and Treatment Planning for Patients with a Lower Extremity Ulcer Richard Neville, MD The Hurt Locker Complications exposed and atlas award presentation (A Teacher, Leader, And Scholar) dissected by expert vascular 8:42 - 8:47 am Honoring John A. Spittell Jr., MD for his contribution to endovascular operatives. education and patient care. Presented by Michael R. Jaff, DO Located in Margaux 2 See page 35 for agenda. 8:47 - 9:55 am LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, Germany Moderator: John Rundback, MD INTRO IN Panel: Matthew Eagleton, MD; Bruce Gray, DO; Lanfroi Graziani, MD; Ziv Haskal, MD; James Joye, DO; Eric Verhoeven, MD, PhD 9:20 - 10:05 am CHALK TALK 9:55 - 10:25 am REFRESHMENT BREAK 9:20 - 10:05 am CRITICAL LIMB ISCHEMIA/TIBIAL Chalk Talk Venous Compression 10:25 - 10:33 am The Endovascular Approach to Acute Limb Ischemia: When and How to Syndromes: When to Consider, Use Thrombectomy and Thrombolysis David Dawson, MD How to Diagnose, Available Treatment Options, and What 10:33 - 10:41 am SPECIAL FEATURE – This Is How I Do It: My Approaches to Alternative to Expect Lower Extremity Vascular Access: Popliteal, Tibial, and Pedal – When and Moderator: How I Use Them Jihad Mustapha, MD Michael Dake, MD Panel: Fritz Angle, MD; 10:41 - 10:50 am Step-by-Step Approach to Pedal Loop Interventions; How to Succeed Clement Darling, MD; Lanfroi Graziani, MD Jason Lee, MD; Suresh Vedantham, MD 10:50 am - 12:00 pm LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, Germany Moderator: Kenneth Rosenfield, MD Located in Alsace 1 INTRO IN Panel: Mark Creager, MD; Clement Darling, MD; Mark Eskandari, MD; Nick Hopkins, MD; Alan Matsumoto, MD; Thomas Tsai, MD 12:00 - 1:20 pm LUNCH / SATELLITE SYMPOSIA26 Agenda subject to change.
1:20 - 2:00 pm LATE-BREAKING CLINICAL TRIALS Moderator: Michael R. Jaff, DO MISCELLANEOUS2:00 - 2:08 pm In-Stent Restenosis in the Visceral and Renal Arteries: Current Views on the Risk, Diagnosis, and Treatment Options Thomas Zeller, MD 2:20 - 3:20 pm2:08 - 2:16 pm Contemporary Surgical Approaches to the Evaluation and Management of DIALOG SESSION Chronic Mesenteric Ischemia Mark Eskandari, MD The Relationship of Blood Flow and Vascular Disease:2:16 - 3:20 pm LIVE CASE DEMONSTRATIONS: Presbyterian Heart Institute Basic Science and Clinical Moderator: Peter Schneider, MD Observations that Emphasize INTRO IN Panel: Subhash Banerjee, MD; Bruce Gray, DO; William Jordan, MD; Important Pathophysiological Stephen Kee, MD; Dierk Scheinert, MD; Suresh Vedantham, MD Principles Moderator:2:20 - 3:20 pm DIALOG SESSION Kenneth Rosenfield, MD Panel: Joshua Beckman, MD;3:20 - 3:50 pm REFRESHMENT BREAK Mark Creager, MD; Jon Matsumura, MD CAROTID and STROKE Located in Alsace 13:50 - 3:57 pm Where Do We Go After CREST? New Studies and Answers to Frequently Asked Questions in the Post-CREST Era Joshua Beckman, MD3:57 - 4:04 pm Carotid Disease Stratification: Is Plaque Composition an Important Factor to Currently Consider Before Selecting Therapy? Jon Matsumura, MD4:04 - 4:11 pm CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Decision Tree When Approaching a Symptomatic Patient with Carotid Artery Disease concurrent sessionS Clement Darling, MD ...Continued v4:11 - 4:18 pm New Strategies, Devices, and Techniques for Carotid Artery Stenting: Opportunities to Improve Outcomes or is This as Good as it Gets? INternational FORUM John Laird, MD International perspectives presented by world-renowned faculty.4:18 - 4:25 pm Acute Stroke Intervention: Is There Something We’re Missing? Located in Margaux 1 See pages 32-33 for agenda. Nick Hopkins, MD4:25 - 4:32 pm Intracranial Update: Current Status of Stents, Flow Diversion, Embolization, etc., to Treat Neurovascular Lesions Colin Derdeyn, MD4:32 - 5:30 pm LIVE CASE DEMONSTRATIONS: Presbyterian Heart Institute Moderator: James Joye, DO INTRO IN Panel: Mark Creager, MD; Colin Derdeyn, MD; Mark Farber, MD; Zvonimir Krajcer, MD; Gary Siskin, MD The Hurt Locker 5:30 pm DAY THREE CONCLUDES/SATELLITE SYMPOSIA Located in Margaux 2 See page 35 for agenda. for updated PROGRAM information visit www.VIVAPVD.com 27